Overview

Naloxone Nasal Spray Pharmacokinetic Study

Status:
Unknown status

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

Summary

This study aims to compare the pharmacokinetics of naloxone when administered as the Mitovie nasal spray (Test Product) and as a solution for injection (Comparator Product) administered intranasally using a mucosal atomization device (MAD).

Phase:

Phase 1

Details

Lead Sponsor:

Mitovie Pharma Ltd

Treatments:

Naloxone
Pharmaceutical Solutions